Oncolytics Biotech, Inc. (ONCY) Q4 2024 Earnings
ONCY·Reported March 7, 2025·Before market open
Diluted EPS came in at $-0.07, beat the $-0.08 consensus by $0.01.
Diluted EPS
$-0.07beat by $0.01
Consensus: $-0.08
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2024 Earnings FAQ
Common questions about Oncolytics Biotech, Inc.'s Q4 2024 earnings report.
Oncolytics Biotech, Inc. (ONCY) reported Q4 2024 earnings on March 7, 2025 before market open.
Oncolytics Biotech, Inc. reported diluted EPS of $-0.07 for Q4 2024.
EPS beat the consensus estimate of $-0.08 by $0.01.